E165D (p.Glu165Asp) variant of SLC40A1 (Ferroportin)
E165D (p.Glu165Asp) in SLC40A1 (Ferroportin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes variant effect predictions and structural context.
E165D (p.Glu165Asp) variant details
- p.Glu165Asp
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- MetaLR 0.63
- MetaSVM 0.05
- SIFT 0.54
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available